Logged in as
Pinch to Zoom Antiplatelet Meds
Identify the blue label
| Last 24 Days | |||
| 1 | 2 | 3 | 4 |
| 5 | 6 | 7 | 8 |
| 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 |
| 17 | 18 | 19 | 20 |
| 21 | 22 | 23 | 24 |
| April 30 | |||
| 0 | 6 | 12 | 18 |
| 1 | 7 | 13 | 19 |
| 2 | 8 | 14 | 20 |
| 3 | 9 | 15 | 21 |
| 4 | 10 | 16 | 22 |
| 5 | 11 | 17 | 23 |
| Yesterday | |||
| 0 | 6 | 12 | 18 |
| 1 | 7 | 13 | 19 |
| 2 | 8 | 14 | 20 |
| 3 | 9 | 15 | 21 |
| 4 | 10 | 16 | 22 |
| 5 | 11 | 17 | 23 |
| Today | |||
| 0 | 6 | 12 | 18 |
| 1 | 7 | 13 | 19 |
| 2 | 8 | 14 | 20 |
| 3 | 9 | 15 | 21 |
| 4 | 10 | 16 | 22 |
| 5 | 11 | 17 | 23 |
×
Irreversible cyclooxygenase inhibitors: Aspirin, Triflusal (Disgren)
Adenosine diphosphate (ADP) receptor inhibitors: Cangrelor (Kengreal), Clopidogrel (Plavix), Prasugrel (Effient), Ticagrelor (Brilinta), Ticlopidine (Ticlid)
Phosphodiesterase inhibitors: Cilostazol (Pletaal)
Protease-activated receptor-1 (PAR-1) antagonists: Vorapaxar (Zontivity)
Glycoprotein IIB/IIIA inhibitors (intravenous use only): Abciximab (ReoPro), Eptifibatide (Integrilin), Tirofiban (Aggrastat)
Adenosine reuptake inhibitors: Dipyridamole (Persantine)
15
1
12
14
0
9
9
8
13
16
13
26
5
9
7
13
5
4
6
5
3
15
9
17
8
5
12
13
8
12
13
9
1
4
9
20
13
17
14
4
4
21
9
0
7
5
5
20
8
10
9
4
1
14
3
12
10
14
14
12
10
8
10
3
8
0
15
2
Websites Wikipedia